Advanced search
Publication Cover
Emerging Microbes & Infections Volume 5, 2016 - Issue 1
Submit an article Journal homepage
2,692
Views
62
CrossRef citations to date
0
Altmetric
Reviews

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases

Qunying MaoNational Institutes for Food and Drug Control, Beijing100050, China
,
Yiping WangNational Institutes for Food and Drug Control, Beijing100050, China
,
Lianlian BianNational Institutes for Food and Drug Control, Beijing100050, China
,
Miao XuNational Institutes for Food and Drug Control, Beijing100050, China
&
Zhenglun LiangNational Institutes for Food and Drug Control, Beijing100050, ChinaCorrespondence[email protected]
Pages 1-7 | Received 29 Jan 2016, Accepted 02 May 2016, Published online: 25 Jan 2019

  • FauquetCM,MayoMA,ManiloffJet al.Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses.Elsevier Academic Press: San Diego.2005,757–778.
  • MirandA,HenquellC,ArchimbaudCet al.Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study.Clin Microbiol Infect2012; 18:E110–E118.
  • MaoQ,WangY,YaoXet al.Coxsackievirus A16: epidemiology, diagnosis, and vaccine.Hum Vaccin Immunother2014; 10:360–367.
  • YipCC,LauSK,WooPCet al.Human enterovirus 71 epidemics: what’s next?Emerg Health Threats J2013; 6:19780.
  • ChenYJ,ChangSC,TsaoKCet al.Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities.PLoS One2012; 7:e52432.
  • FujimotoT,IizukaS,EnomotoMet al.Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011.Emerg Infect Dis2012; 18:337–339.
  • PuenpaJ,ChieochansinT,LinsuwanonP.Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012.Emerg Infect Dis2013; 19:641–643.
  • LiJL,YuanJ,YangFet al.Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent.J Infect2014; 69:299–303.
  • YangQ,DingJ,CaoJet al.Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10.J Med Virol2015; 87:954–960.
  • NiH,YiB,YinJet al.Epidemiological and aetiological characteristics of hand, foot and mouth disease in Ningbo, China, 2008-2011.J Clin Virol2012; 54:342–348.
  • TianH,ZhangY,SunQet al.Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3.PLoS One2014; 9:e84233.
  • KimDS,NamJH.Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.Expert Opin Biol Ther2010; 10:179–190.
  • KimHJ,KangB,HwangSet al.Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008.Virol J2012; 9:38.
  • China Food and Drug AdministrationCFDA PIZHUN CHANGDAO BINGDU 71XING MIEHUOYIMIAO SHENGCHAN SHANGSHI. Chinese.CFDA: Beijing.2015.Available athttp://www.sfda.gov.cn/WS01/CL0051/136853.html (accessed on 27 January 2016).
  • China Food and Drug AdministrationCFDA PIZHUN SHANGSHIYAOPIN GONGGAO. Chinese.CFDA: Beijing.2016.Available athttp://www.sda.gov.cn/WS01/CL0087/142000.html (accessed on 27 January 2016).
  • CaiY,KuZ,LiuQet al.A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.Vaccine2014; 32:2406–2412.
  • KuZ,LiuQ,YeXet al.A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.Vaccine2014; 32:4296–4303.
  • BianL,WangY,YaoXet al.Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide.Expert Rev Anti Infect Ther2015; 13:1061–1071.
  • AngLW,KohBK,ChanKPet al.Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007.Ann Acad Med Singapore2009; 28:106–112.
  • LinsuwanonP,PuenpaJ,HuangSWet al.Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations.J Biomed Sci2014; 21:16.
  • LiuSL,PanH,LiuPet al.Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014.Rev Med Virol2015; 25:115–128.
  • XingW,LiaoQ,ViboudCet al.Hand, foot and mouth disease in China, 2008-12: an epidemiological study.Lancet Infect Dis2014; 14:308–318.
  • RobinsonCR,DoaneFW,RhodesAJ.Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus.Can Med Assoc J1958; 79:615–621.
  • FersonMJ,BellSM.Outbreak of coxsackievirus A16 hand, foot, and mouth disease in a child day-care center.Am J Public Health1991; 81:1675–1676.
  • BendigJW,FlemingDM.Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales.Commun Dis Rep CDR Rev1996; 6:R81–R86.
  • ChangLY.Enterovirus 71 in Taiwan.Pediatr Neonatol2008; 49:103–112.
  • TuPV,ThaoNTT,PereraDet al.Epidemiologic and virologic investigation of hand, foot and mouth disease, Southern Vietnam, 2005.Emerg Infect Dis2007; 13:1733–1741.
  • KarBR,DwibediB,KarSK.An outbreak of hand, foot and mouth disease in Bhubaneswar, Odisha.Indian Pediatr2013; 50:139–142.
  • WangCY,Li LuF,WuMHet al.Fatal coxsackievirus A16 infection.Pediatr Infect Dis J2004; 23:275–276.
  • WuY,YeoA,PhoonMCet al.The largest outbreak of hand, foot and mouth disease in Singapore in 2008: the role of enterovirus71 and coxsackievirus A strains.Int J Infect Dis2010; 14:e1076.
  • MontesM,ArtiedaJ,PiñeiroLDet al.Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011.Emerg Infect Dis2013; 19:676–678.
  • PuenpaJ,MauleekoonphairojJ,LinsuwanonPet al.Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012.PLoS One2014; 9:e98888.
  • Centers for Disease Control and Prevention (CDC).Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6–Alabama, Connecticut, California, and Nevada, November 2011-February 2012.MMWR Morb Mortal Wkly Rep2012; 61:213–214.
  • SinclairC,GauntE,SimmondsPet al.Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014.Euro Surveill2014; 19:20745.
  • KimDS,NamJH.Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy.Hum Vaccin2011; 7:410–416.
  • BaekK,ParkK,JungEet al.Molecular and epidemiological characterization of enteroviruses isolated in Chungnam, Korea from 2005 to 2006.J Microbiol Biotechnol2009; 19:1055–1064.
  • BaekK,YeoS,LeeBet al.Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009.Virol J2011; 8:297.
  • ShahVA,ChongCY,ChanKPet al.Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore.Ann Acad Med Singapore2003; 32:381–387.
  • HsuCH,LuCY,ShaoPLet al.Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008.J Microbiol Immunol Infect2011; 44:265–273.
  • YaoX,BianLL,LuWWet al.Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.J Med Virol2015; 87:2009–2017.
  • ChenP,TaoZ,SongYet al.A coxsackievirus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009.J Med Virol2013; 85:483–489.
  • MooreM,KaplanMH,McPheeJet al.Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79.Public Health Rep1984; 99:515–522.
  • BaeEY,LeeEJ,HanSBet al.A case of myocarditis following neonatal meningitis caused by coxsackievirus B1 in spite of intravenous immunoglobulin treatment.J Trop Pediatr2014; 60:164–167.
  • TapparelC,SiegristF,PettyTJet al.Picornavirus and enterovirus diversity with associated human diseases.Infect Genet Evol2013; 14:282–293.
  • PeiYW,WangJX,LinYet al.Genetic analysis of Echovirus 30 isolated from hand-foot-mouth disease causes and healthy controls from Shandong, China in 2010.Chin J Viral Dis2013; 3:367–371.
  • ZhangT,DuJ,XueYet al.Epidemics and frequent recombination within species in outbreaks of human enterovirus B-associated hand,foot and mouth disease in Shandong China in 2010 and 2011.PLoS One2013; 8:e67157.
  • HeP,ChenC,DiBet al.Spectrum analysis of hand, foot and mouth disease in Guangzhou in 2011.J Trop Med2012; 12:613–616.
  • KumarA,ShuklaD,KumarRet al.Molecular identification of enteroviruses associated with aseptic meningitis in children from India.Arch Virol2013; 158:211–215.
  • MartinoTA,LiuP,SoleMJ.Viral infection and the pathogenesis of dilated cardiomyopathy.Circ Res1994; 74:182–188.
  • DumaidiK,FrantzidouF,PapaAet al.Enterovirus meningitis in Greece from 2003-2005: diagnosis, CSF laboratory findings, and clinical manifestations.J Clin Lab Anal2006; 20:177–183.
  • ZhuFC,MengFY,LiJXet al.Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Lancet2013; 381:2024–2032.
  • ChengA,FungCP,LiuCCet al.A phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.Vaccine2013; 31:2471–2476.
  • National Institutes of HealthSafety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71. ClinicalTrials.gov Identifier: NCT01376479.NIH: USA.2015.Available athttps://prsinfo.clinicaltrial.gov/ct2/show/nct01376479?term=inviragen±%28singapore%29±pte±ltd.&rank=1%202013 (accessed 27 January 27 2016).
  • WuCY,LinYW,KuoCHet al.Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse.PLoS One2015; 10:e0136420.
  • AritaM,NagataN,IwataNet al.An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.J. Virol2007; 81:9386–9395.
  • ChungYC,HoMS,WuJCet al.Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.Vaccine2008; 26:1855–1862.
  • KuZ,YeX,HuangXet al.Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.PLoS One2013; 8:e57601.
  • LiuQ,ShiJ,HuangXet al.A murine model of coxsackievirus A16 infection for anti-viral evaluation.Antiviral Res2014; 105:26–31.
  • LiJ,LiuG,LiuXet al.Optimization and characterization of candidate strain for coxsackievirus A16 inactivated vaccine.Viruses2015; 7:3891–3909.
  • ShiJ,HuangX,LiuQet al.Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16.Vaccine2013; 31:2130–2136.
  • ZhaoH,LiHY,HanJFet al.Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against coxsackievirus A16 in mice.Appl Microbiol Biotechnol2013; 97:10445–10452.
  • GongM,ZhuH,ZhouJet al.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.J Virol2014; 88:6444–6452.
  • SomasundaramB,ChangC,FanYYet al.Characterizing enterovirus 71 and coxsackievirus A16 virus-like particles production in insect cells.Methods2016; 95:38–45.
  • ChenYJ,MengFY,MaoQet al.Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinicaltrial.Hum Vaccin Immunother2014; 10:1366–1372.
  • LiJX,SongYF,WangLet al.Two-year efficacy and immunogenicity of Sinovac enterovirus 71 vaccine against hand, foot and mouth disease in children.Expert Rev Vaccines2015; 15:129–137.
  • LiuL,MoZ,LiangZet al.Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.BMC Med2015; 13:226.
  • ZhuFC,LiangZL,LiXLet al.Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial.Lancet2013; 381:1037–1045.
  • MaoQ,WangY,ShaoJet al.The compatibility of inactivated-enterovirus 71 vaccination with coxsackievirus A16 and Poliovirus immunizations in humans and animals.Hum Vaccin Immunother2015; 11:2723–2733.
  • LiangZ,MaoQ,GaoQet al.Establishing China’s national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.Vaccine2011; 29:9668–9674.
  • LiangZ,WangJ.EV71 vaccine, an invaluable gift for children.Clin Transl Immunology2014; 3:e28.
  • CaiY,LiuQ,HuangXet al.Active immunization with a coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.Vaccine2013; 31:2215–2221.
  • Qi AnW,Guo SuZ,Wen PanRet al.The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.Hum Vaccin Immunother2014; 10:628–639.
  • YangE,ChengC,ZhangYet al.Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line.Hum Vaccin Immunother2014; 10:1266–1273.
  • SunS,JiangL,LiangZet al.Evaluation of monovalent and bivalent vaccines against lethal enterovirus 71 and coxsackievirus A16 infection in newborn mice.Hum Vaccin Immunother2014; 10:2885–2895.
  • LiuQ,TongX,HuangZ.Towards broadly protective polyvalent vaccines against hand, foot and mouth disease.Microbes Infect2015; 17:155–162.
  • SeeDM,TillesJG.Occurrence of coxsackievirus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine.Proc Soc Exp Biol Med1997; 216:52–56.
  • WuXY,ZhaoTQ,TianYet al.A bivalent VP1 gene vaccine against Coxsackie virus B1/B3.Natl Med J China2001; 81:480–484.
  • LiuZ,CarthyCM,CheungPet al.Structural and functional analysis of the 5′ untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants.Virology1999; 265:206–217.
  • M’hadheb-GharbiMB,El HiarR,PaulousSet al.Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation.J Mol Microbiol Biotechnol2008; 14:147–156.
  • LanJ,GaoZ,XiongHet al.Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.Vaccine2011; 29:6894–6902.
  • Economic Daily. EV71 SHOUZUKOU YIMIAO KAISHI JIEZHONG, MEIJI JIAGE BU CHAO 218 YUAN. Chinese. Beijing: ED, 2016. Available athttp://baby.ce.cn/qt/201603/29/t20160329_3652260.shtml (accessed on 13 April 2016).
  • GanZK,JinH,LiJXet al.Disease burden of enterovirus 71 in rural central China: a community-based survey.Hum Vaccin Immunother2015; 11:2400–2405.
  • LeeBY,WateskaAR,BaileyRRet al.Forecasting the economic value of an enterovirus 71 (EV71) vaccine.Vaccine2010; 28:7731–7736.
  • LiL,YinH,AnZet al.Considerations for developing an immunization strategy with enterovirus 71 vaccine.Vaccine2015; 33:1107–1112.
  • KleinM,ChongP.Is a multivalent hand, foot, and mouth disease vaccine feasible?Hum Vaccin Immunother2015; 11:2688–2704.
  • LiuCC,ChowYH,ChongPet al.Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.Vaccine2014; 32:6177–6182.
  • CaineEA,FuchsJ,DasSCet al.Efficacy of a trivalent hand, foot, and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice.Viruses2015; 7:5919–5932.
  • LiuCC,GuoMS,WuSRet al.Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.Antiviral Res2016; 129:58–66.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.